Have your own idea? Try our Stock Screener
UPDATED Nov 20, 2024
Discover Swedish Growth Stocks that are on the OMX. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MINEST | SEK 2.31 | -17.5% | -70.5% | SEK 448.4m | n/a | PS17x | E199.1% | n/a | Capital Goods | ||
AAC | SEK 43.85 | 0.8% | 19.2% | SEK 258.4m | n/a | PB0.4x | E165.7% | n/a | Capital Goods | ||
STUDBO | SEK 1.59 | -0.9% | 67.0% | SEK 899.1m | n/a | PS2.1x | E144.3% | n/a | Real Estate Management and Development | ||
NAVIGO STAM | SEK 2.34 | -6.0% | -62.6% | SEK 362.3m | SEK 5.00 | PB0.1x | E139.0% | n/a | Diversified Financials | ||
CTM | SEK 4.15 | -1.3% | -65.9% | SEK 313.6m | SEK 29.99 | PB0.2x | E138.0% | 0% | Media | ||
CHECK | SEK 18.00 | 2.9% | -55.2% | SEK 542.1m | SEK 39.75 | PS4.9x | E137.3% | n/a | Software | ||
SKOLON | SEK 34.10 | -8.8% | 88.4% | SEK 905.2m | SEK 37.50 | PS6.1x | E135.5% | 1.6% | Software | ||
XSPRAY | SEK 42.20 | -3.8% | 6.8% | SEK 1.4b | SEK 76.00 | PB2.4x | E134.8% | n/a | Pharmaceuticals & Biotech | ||
BICO | SEK 34.28 | -8.0% | -36.4% | SEK 2.4b | SEK 100.00 | PB0.8x | E130.3% | n/a | Pharmaceuticals & Biotech | ||
XBRANE | SEK 0.20 | 1.2% | -98.9% | SEK 310.5m | n/a | PS1.6x | E130.2% | n/a | Pharmaceuticals & Biotech | ||
FRAG | SEK 0.019 | -5.0% | -98.9% | SEK 64.4m | SEK 3.50 | PB0.7x | E130.2% | n/a | Media | ||
NEWBRY | SEK 3.62 | -4.7% | 0.8% | SEK 88.3m | SEK 8.00 | PS2.4x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 1.92 | 1.1% | -6.1% | SEK 207.1m | SEK 2.90 | PS1.9x | E129.4% | n/a | Tech | ||
VPLAY B | SEK 0.66 | 4.5% | -97.4% | SEK 3.0b | SEK 1.03 | PB0.8x | E127.3% | 0% | Media | ||
CINT | SEK 11.44 | -12.0% | 25.9% | SEK 2.4b | SEK 13.51 | PS1.1x | E126.7% | n/a | Software | ||
MODEL | SEK 11.70 | -1.7% | n/a | SEK 199.8m | SEK 22.00 | PS2.5x | E123.7% | n/a | Software | ||
PREC | SEK 4.64 | 58.4% | 409.9% | SEK 359.0m | SEK 3.40 | PS4.2x | E123.2% | n/a | Software | ||
SBB B | SEK 4.03 | -4.0% | -0.5% | SEK 6.8b | SEK 2.80 | PS1x | E122.8% | 29.8% | Real Estate Management and Development | ||
SERT | SEK 1.28 | 24.3% | 142.4% | SEK 264.6m | SEK 1.70 | PS5.6x | E121.2% | n/a | Tech | ||
NEXAM | SEK 4.04 | 2.3% | 28.7% | SEK 326.9m | SEK 4.25 | PS1.6x | E120.9% | n/a | Materials | ||
ACAST | SEK 15.00 | 2.4% | 71.8% | SEK 2.7b | SEK 20.50 | PS1.5x | E120.9% | n/a | Media | ||
LYKO A | SEK 81.50 | -11.1% | -15.8% | SEK 1.2b | SEK 102.50 | PB3x | E120.3% | n/a | Retail | ||
SENZA | SEK 7.00 | -1.4% | 4.2% | SEK 206.5m | SEK 16.00 | PS3.5x | E120.0% | n/a | Pharmaceuticals & Biotech | ||
KAR | SEK 79.00 | -1.3% | 44.7% | SEK 8.5b | SEK 96.67 | PE5013.1x | E119.4% | 0% | Media |